Clinical efficacy of central-peripheral repetitive magnetic stimulation on urinary retention after spinal cord injury

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200067143

Enrollment

Unknown

Registered

2022-12-27

Start date

2023-01-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary retention after spinal cord injury

Interventions

Group A:False stimulation

Group B:Transcranial magnetic stimulation

Group C:Transsacral nerve root magnetic stimulation

Group D:Transcranial magnetic stimulation + transsacral nerve root stimulation

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Meeting the classification criteria for spinal cord injury in the International Standard for Neurological Classification of Spinal Cord Injury and confirmed by MRI or CT examination. (2) Clinical manifestation of urinary retention, i.e., the patient has a residual urine volume >100 ml after emptying the bladder. (3) Age 18-60 years, regardless of gender. (4) Patients graded B, C, or D according to the American Spinal Cord Injury Association functional assessment criteria (ASIA). (5) Duration of disease between 1 month and 2 years. (6) Voluntarily participated in this study and signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Complicated serious urinary tract infections, malignant tumors, stones, etc. (2) Patients with previous history of seizures, central nervous system diseases, psychiatric diseases, psychological diseases (3) Patients with cranial and sacrococcygeal metal implants, increased intracranial pressure, heart disease, pacemakers, drug pumps, tricyclic antidepressants, neuroleptics, or a family history of epilepsy that precludes treatment with MS (4) Urinary dysfunction due to other diseases. (5) Those who have undergone urethral sphincterotomy or cystotomy. (6) Patients with unstable vital signs, hemodynamic instability, patients with skin breakdown, patients with bleeding tendencies (7) Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
Functional brain imaging assessment;Residual bladder urine volume;Changes in urination;Glazer Evaluation;Quality of life score;	—

Countries

China

Contacts

Public Contactzhongyanbiao

The First Affiliated Hospital of Gannan Medical University

zhongyb2010@163.com18201826956

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026